Bell Investment Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bell Investment Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34	Closed	-$1.34K	–	2031
2023 Q2	$1.34K	Buy	34 +13	+62%	+$459	﹤0.01%	1483
2023 Q1	$511	Buy	+21	New	+$460	﹤0.01%	1820

Bell Investment Advisors's ISEE Position: Q3 2023 in Review

Bell Investment Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 34 shares — an estimated $1.34K sold.

Bell Investment Advisors first reported a position in ISEE in Q1 2023 and held it in 2 quarters. The position peaked at $1.34K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Bell Investment Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bell Investment Advisors sold 34 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.34K.
Bell Investment Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Bell Investment Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.34K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bell Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.